ArticleJournal of cardiovascular pharmacology and therapeutics2009

The cyclic GMP modulators YC-1 and zaprinast reduce vessel remodeling through antiproliferative and proapoptotic effects.

Amit N Keswani et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.